322 related articles for article (PubMed ID: 33667962)
1. Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.
Liu BM; Martins TB; Peterson LK; Hill HR
Cytokine; 2021 Jun; 142():155478. PubMed ID: 33667962
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
3. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
Front Immunol; 2021; 12():745515. PubMed ID: 34858403
[TBL] [Abstract][Full Text] [Related]
4. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
[TBL] [Abstract][Full Text] [Related]
5. Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases.
Guest PC; Abbasifard M; Jamialahmadi T; Majeed M; Kesharwani P; Sahebkar A
Methods Mol Biol; 2022; 2511():245-256. PubMed ID: 35838965
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
[TBL] [Abstract][Full Text] [Related]
7. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
9. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
10. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
Cabler SS; French AR; Orvedahl A
Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
[TBL] [Abstract][Full Text] [Related]
11. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
Shawki MA; Elsayed NS; Mantawy EM; Said RS
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
[TBL] [Abstract][Full Text] [Related]
12. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Darif D; Hammi I; Kihel A; El Idrissi Saik I; Guessous F; Akarid K
Microb Pathog; 2021 Apr; 153():104799. PubMed ID: 33609650
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
14. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
Zheng M; Karki R; Williams EP; Yang D; Fitzpatrick E; Vogel P; Jonsson CB; Kanneganti TD
Nat Immunol; 2021 Jul; 22(7):829-838. PubMed ID: 33963333
[TBL] [Abstract][Full Text] [Related]
15. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.
Cheon SY; Koo BN
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684
[TBL] [Abstract][Full Text] [Related]
19. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.
Land WG
Genes Immun; 2021 Jul; 22(3):141-160. PubMed ID: 34140652
[TBL] [Abstract][Full Text] [Related]
20. T cell immunobiology and cytokine storm of COVID-19.
Luo XH; Zhu Y; Mao J; Du RC
Scand J Immunol; 2021 Mar; 93(3):e12989. PubMed ID: 33113222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
